Drug Type Oncolytic product |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Adze Biotechnology, Inc.Startup |
Active Organization Adze Biotechnology, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma Multiforme | Preclinical | US | Adze Biotechnology, Inc.Startup | 19 Jul 2023 |